Table: Mochida Pharm -2019/20 group results

Mochida Pharmaceutical

15/05/2020 06:00

May 15 (Reuters)- 
          Mochida Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          101.80          109.64         102.00                 
               (-7.2 pct)      (+2.7 pct)     (+0.2 pct)               
  Operating        8.81           10.59           7.80                 
               (-16.8 pct)     (-9.2 pct)     (-11.4 pct)              
  Recurring        9.15           10.93           8.20                 
               (-16.2 pct)     (-9.0 pct)     (-10.4 pct)              
  Net
  Net              4.60            8.44           5.80                 
               (-45.5 pct)     (-6.5 pct)     (+26.1 pct)              
  EPS          117.56 yen      212.87 yen     149.66 yen               
  Ann Div       80.00 yen      170.00 yen      80.00 yen               
  -Q2 Div       40.00 yen       80.00 yen      40.00 yen               
  -Q4 Div       40.00 yen       90.00 yen      40.00 yen               
  
  NOTE - Mochida Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T